Support MS Research

Sign Up to eNewsletter

Be the first to receive the latest news on MS Research.

 

News

Showing 1 to 10 of 811

International attention focussed on progressive MS

11th January, 2017

One of the core goals of the International Progressive MS Alliance is to not only bring together researchers and fund research into progressive MS, but also to focus the attention and efforts of the

Read More

Full trial results released for new progressive MS treatment ocrelizumab

10th January, 2017

Full clinical trial results for ocrelizumab, a new treatment for primary progressive and relapsing MS have been formally published

Read More

Zinbryta has been recommended for inclusion on the PBS

20th December, 2016

Zinbryta (daclizumab) has been recommended for inclusion on the Pharmaceutical Benefits Scheme by the PBAC at their November meeting

Read More

Ageing myelin, the cause of MS?

8th December, 2016

Researchers at the University of Wollongong have found an interesting phenomena when myelin ages which may be a contributing factor in the development of MS.

Read More

Priorities for research – listening to the MS community

7th December, 2016

Earlier this year we asked the Australian MS community, to let us know your thoughts on the priorities for the many different areas of MS research

Read More

New study shows benefits of current treatments for people with advanced MS

7th December, 2016

Contrary to the notion that current treatments only benefit early stage MS, new research has shown that taking treatments that modify the immune system can improve the disease course even in people with

Read More

Employment rates improving for Australians with MS

7th December, 2016

A new study shows that employment rates are up for people with MS in Australia and the gap between people with MS and the general population is narrowing

Read More

Investment conference raises $3 million for medical research

7th December, 2016

The influential Australian Financial Review journalist, Joe Aston, called the recent Sohn Hearts and Minds Investment conference a “triumph”, raising $3 million for medical research.

Read More

MS Research Australia and the global MS effort

7th December, 2016

Collaboration has become an important requirement for progress and achievement in business, industry and the not-for-profit sector. At MS Research Australia we are proud that collaboration has been one of

Read More

Clinical trials – determining the safety and effectiveness of treatments

7th December, 2016

There is a lot of interest in the MS community in the potential treatment option for MS known as autologous haematopoietic stem cell transplant (AHSCT). Research into this form of treatment for MS has

Read More

Showing 1 to 10 of 811